Insulin like growth factor I (IGF-I) is believed to be a potent para/ autocrine stimulator of Leydig cell function in adult testis. We investigated whether IGF-I is also an intratesticular regulator of fetal Leydig cell function by measuring its production in the fetal testis and its ability to affect testicular steroidogenesis during fetal development.
A
LTHOUGH it is well established that testicular function is mainly controlled by the gonadotropins LH and FSH (1) , there is now considerable evidence indicating that local factors are extremely important in regulating the functions of the testis (reviewed in Refs. [2] [3] [4] . One of these factors, insulin-like growth factor I (IGF-I), is believed to be a potent para/autocrine stimulator of Leydig cell function (reviewed in Refs. 5 and 6) . This is suggested by experimental and clinical data showing that isolated GH deficiency and resistance to GH are associated with delayed puberty and a poor response to exogenous hCG (7) . Several laboratories have also demonstrated IGF-I immunoreactivity (8, 9) and IGF-I messenger RNA (mRNA) (10) in the adult rat testis. Immunostainable IGF-I has been found in adult human testes (11) . Cultures of Sertoli and Leydig cells from adult rats and immature pigs secrete immunoreactive IGF-I into the medium, and this secretion is enhanced by FSH (Sertoli cells) or LH (Leydig cells) (12, 13) .
Type I receptors for IGF-I have been found on human, pig, and rat Leydig cells (14 -16) , and IGF-I enhances the differentiated functions of Leydig cells (5, 6, 17) . IGF-I stimulates the hCG-supported production of cAMP and testosterone by cultures of rat (18) and pig (19) Leydig cells. The response to cAMP analogs is also enhanced (16, 19) , suggesting that IGF-I potentiates the action of LH/hCG at sites both proximal and distal to cAMP generation. IGF-I increases the number of LH/hCG receptors (16, 20) and the amount of LH/hCG receptor mRNA (21) as well as the activities of several steroidogenic enzymes and the amounts of mRNAs encoding them (21) (22) (23) .
Further evidence for the importance of IGF-I for Leydig cell maturation and steroidogenic capacity was obtained by in vivo studies showing that treatment of GH-deficient Snell dwarf mice with hGH or IGF-I for 7 days produced a marked increase in the number of hCG receptors and in the steroidogenic responsiveness to this hormone (24) . Lastly, the crucial role of IGF-I in the development and function of Leydig cells was obtained in studies of IGF-I gene knock-out mice (25) . The testes of these animals were reduced in size and had fewer and smaller Leydig cells than normal, and the plasma testosterone levels were markedly reduced. Basal and LHstimulated testosterone productions by testicular slices in vitro were also impaired.
All of these studies were performed on adult animals, and there are no data available on the role of IGF-I in the fetal testis. To determine whether IGF-I can be an intratesticular modulator of fetal Leydig cell function and differentiation, we first investigated the expression and secretion of IGF-I by the fetal testis, and second we studied its effect on testosterone production by organotypic cultures and dispersed fetal Leydig cells in vitro. The effects of IGF-I were also compared with those of insulin.
Materials and Methods Animals
Female Wistar rats from Iffa Credo (l'Arbresle, France) were housed under a controlled photoperiod (lights on, 0600 -2000 h) and fed a commercial diet (U.A.R., Villemoisson sur Orge, France) plus tap water ad libitum. Males were caged with females for the night. As the estimated time of ovulation and fertilization was 0200 h, the day following an overnight mating was counted as day 0.5. On days 13.5-20.5 of gestation, pregnant rats were anesthetized by an ip injection of 4 mg/ml sodium pentobarbital (Sanofi, Libourne, France), and the testes were removed aseptically from the fetuses under a binocular microscope and immediately explanted in vitro. Gonadal sex is not yet morphologically differentiated on day 13.5, so both presumptive ovaries and testes were explanted, and the sex of the gonads was determined after culture, because 13.5 day fetal testes secrete testosterone after 2 days in culture, whereas fetal ovaries do not (26) .
Chemicals and solutions
The explants were placed in medium 199 containing 4.18 mm sodium bicarbonate (Flow Laboratories, Rockville, MD), 0.35% glutamine (Flow Laboratories), 100 IU/ml Specilline G (Specia, France), 40 g/ml gentamicin (Schering-Plough, Levallois-Perret, France), and 5 g/ml transferrin (Sigma Chemical Co., St. Louis, MO). Dispersed Leydig cells were cultured in Ham's F-12-DMEM (1:1; Life Technologies, Grand Island, NY) containing 5 g/ml transferrin (Sigma) and 40 g/ml gentamicin (Gentalline, Schering-Plough). Ovine (o) LH (NIH LH S19; 1.01 NIH LH.S1 units/mg) was a gift from Dr. Parlow (NIDDK, Bethesda, MD). Recombinant human (h) FSH (12000 IU/mg) was a gift from Dr. B. Mannaerts (Organon International, Oss, The Netherlands) (27) . (Bu) 2 cAMP, soybean trypsin inhibitor, deoxyribonuclease I, nitro blue tetrazolium (NBT), NAD, and human insulin were purchased from Sigma. Collagenase was obtained from Serva (Heidelberg, Germany). Recombinant IGF-I was obtained from Kabi-Vitrum (Stockholm, Sweden).
Hybridization probe
A 2.6-kb fragment of IGF-I complementary DNA (a gift from M. Jansen, Utrecht, The Netherlands) (28) , was labeled to a specific activity of 10 9 dpm/g DNA using [␣-32 P]deoxy-CTP and the Amersham Megaprime DNA labeling kit (Amersham France, Les Ulis, France).
Organ cultures
Testes removed on day 13.5 were cultured on stainless steel grids placed in organ culture dishes containing 0.8 ml culture medium (Falcon, Grenoble, France) (26) . Testes explanted at later ages were cultured on Millipore culture filters (Millipore, Bedford, MA) as previously described (29) . Briefly, 16.5-and 18.5-day-old fetal testes were cut into two pieces, and 20.5-day-old fetal testes into eight pieces. All pieces from the same testis were placed on a Millipore filter (pore size, 0.45 m). The filter bearing the pieces of testis was floated on 1.5 ml culture medium in 35-mm diameter tissue culture dishes and maintained at 37 C. To study IGF-I secretion, eight testes from day 20.5 fetuses and 32 testes from day 16.5 fetuses were pooled on the same Millipore filter to obtain detectable secretion of IGF-I. Testes were cultured for 3 days at 37 C in a humidified atmosphere containing 95% air-5% CO 2 . The medium was changed every 24 h.
Culture of dispersed fetal testicular cells
The technique used was essentially that described by Habert and Brignaschi (29) with minor modifications (30) . Briefly, at least 40 testes from 20.5-day-old fetuses or 60 from 16.5-day-old fetuses were carefully minced and incubated for 30 min at 32 C in 5 ml calcium-and magnesium-free Dulbecco's PBS (Life Technologies) containing 0.2 mg/ml collagenase, 0.05 mg/ml soybean trypsin inhibitor, 0.01 mg/ml deoxyribonuclease, and 40 g/ml gentamicin, with gentle shaking. The testes were also disrupted mechanically at 15 and 25 min by repeated pipetting. The digested testes were diluted with 30 ml Dulbecco's PBS, and the cells were collected by centrifugation for 20 min at 100 ϫ g. The pellets were resuspended in 30 ml Dulbecco's PBS and allowed to sediment under gravity for 12 min. The undigested tubules settled first, and the interstitial cells, containing the Leydig cells, were collected in the supernatant. The supernatant was centrifuged at 100 ϫ g for 20 min, and the resulting pellet was resuspended in culture medium. The cells were counted in an hemocytometer, and less than 10% of the cells were associated in clumps of more than 5 cells. Cell viability was tested by trypan blue (0.04%) exclusion, and more than 90% of the cells were viable. The cells were placed in 96-well culture dishes (diameter, 6.4 mm) at 0.7 ϫ 10 5 -10 5 cells/100 l/well and precultured in a humidified atmosphere of 5% CO 2 in air in DMEM-Ham's F-12 (1:1) plus 0.4% FCS for the first day (D0) to allow the cells to attach. On the following days (D1 to D3), the cells were cultured without FCS in the presence or absence of IGF-I (50 ng/ml), insulin (50 ng/ml), LH (100 ng/ml) or (Bu) 2 cAMP (1 mm), and the medium was changed every 24 h. Bromodeoxyuridine (BrdU) was added to some cultures for the last 3 h.
At the end of D3, the cells were harvested by trypsinization (trypsin-EDTA solution, Life Technologies) and counted in a hemocytometer. In other wells, the Leydig cells were identified by cytochemical detection of 3␤-hydroxysteroid dehydrogenase activity (3␤HSD) and counted. Briefly, multiwell dishes containing attached cells and culture medium were frozen and stored at Ϫ80 C. They were thawed immediately before use, and the reaction mixture was added to the culture medium to final concentrations of 0.25 mg/ml NBT, 0.28 mg/ml nicotinamide, 0.60 mg/ml NAD, and 0.05 mg/ml dehydroepiandrosterone (previously diluted in dimethylformamide). The dishes were incubated for 4 h at 37 C in 95% air-5% CO 2 . The dark blue positive cells (3␤HSD positive) in each well were counted under an inverted microscope. The percentage of 3␤HSD-positive cells was 1.31 Ϯ 0.11% for day 16.5 fetal cultures and 1.01 Ϯ 0.06% for day 20.5 fetal cultures (three to five experiments with two to six determinations for each experiment).
Colocalization of BrdU with 3␤HSD staining
Dispersed testicular cells, taken from fetal testes on day 16.5, were cultured in a glass Lab-Tek chamber (Lab-Tek, Naperville, IL). They were labeled by incubation with BrdU and 5-fluoro-2Ј-deoxyuridine (labeling reagent diluted 1:100 according to the manufacturer's instructions, Amersham, Aylesbury, UK) on D3 for the last 3 h of culture. Then, the medium was replaced by control medium, and the glass Lab-Tek chamber containing attached cells and culture medium was frozen and stored at Ϫ20 C. Immediately before use, the Lab-Tek chamber was thawed, and the reaction mixture was added to the culture medium to give final concentrations of 0.25 mg/ml NBT, 0.28 mg/ml nicotinamide, 0.60 mg/ml NAD, and 0.05 mg/ml dehydroepiandrosterone (from a stock solution in dimethylformamide). The dishes were incubated for 4 h at 37 C. BrdU incorporation into proliferating cells was detected by immunocytochemistry according to the manufacturer's recommendations. Briefly, cells were washed with culture medium and fixed in Bouin's fluid. The cells were washed with PBS and incubated with 0.3% H 2 O 2 in methanol for 30 min at 20 C to inactivate endogenous peroxidases. Cells were then washed several times with PBS and incubated with a mouse anti-BrdU monoclonal antibody (cell proliferation kit, Amersham) for 1 h at 20 C. The antibody bound to the nuclei was detected by a peroxidase-linked antimouse IgG. Cells were then stained with 3,3Ј-diaminobenzidine (Sigma) and counterstained by brief immersion in hematoxylin. The percentage of dark blue positive cells (3␤HSD positive) with a positive immunoreaction to BrdU was counted (Fig 1) .
Testosterone RIA
The testosterone secreted into the medium was measured in duplicate by RIA (26) . In most cases, no extraction or chromatography was performed on the medium because 17␤-hydroxy-5␣-androstan-3-one, which is the only steroid that cross-reacts (64%) significantly with testosterone, is secreted in minute amounts by the fetal rat testis (31) . When testosterone production was too low (day 13.5 testis and testicular cells from fetuses cultured in the absence of LH), the medium was first concentrated by extraction with ethyl acetate as previously described (32) .
IGF-I RIA
IGF-I was separated from its binding proteins (IGFBP) by acidethanol extraction (12, 33) . Briefly, fetal testes (eight testes from day 20.5 fetuses and 32 testes from day 16.5 fetuses) were homogenized in acetic acid (50 mm) in a Kontes microhomogenizer (Kontes Co., Vineland, NJ). The homogenates (for IGF-I content) and culture media (for secreted IGF-I) were mixed with acetic acid (1 m, final concentration). Then, ethanol was added (1:4). After centrifugation, the supernatants were lyophilized, and IGF-I was measured in the dry extracts by RIA using recombinant IGF-I as a standard (34) . Briefly, samples were incubated with a specific polyclonal anti-IGF-I rabbit antibody for 1 h at 4 C and then labeled IGF-I was added overnight. Antibody-bound and free IGF-I were separated using a goat antirabbit IgG antibody and polyethylene glycol (6%). The limit of sensitivity of the assay was 250 pg/ml, and the interassay coefficient of variation was 8.2% for a sample containing 5 ng/ml IGF-I.
The accuracy of the IGF-I determination in the culture medium was assessed by adding three amounts of IGF-I (1, 5, and 20 ng/ml) to control and conditioned media from the fifth day of testicular culture, as conditioned media may contain IGFBP, which could interfere with RIA. The amounts of IGF-I measured in the control and conditioned media were very similar to those expected (regression coefficient, r ϭ 1.000 and r ϭ 0.997; slope of regression line ϭ 0.963 and 1.005; y-intercept of the regression line ϭ 0.130 and 0.066 ng/ml for control and conditioned medium, respectively; n ϭ 3-6).
Northern blot analysis of IGF-I transcripts
Twenty testes from 20.5-day-old rat fetuses and one testis from a 19-day-old immature rat were harvested in 4 m guanidine thiocyanate.
Total RNA was extracted (35) and denatured by heating (65 C for 15 min), and aliquots (30 g) were electrophoresed through a 1% agarose gel containing 10% formaldehyde. The RNAs were transferred by capillarity to Hybond-N nylon membranes (Amersham) and cross-linked to the membrane by irradiation with UV light for 2 min and baking at 80 C for 2 h. The membranes were prehybridized for at least 2 h at 50 C in 50% formamide; 0.9 m NaCl, 50 mm sodium phosphate (pH 7.5), and 5 mm EDTA; 5 ϫ Denhardt's solution (0.1% Ficoll 400, 0.1% polyvinylpyrolidone, and 0.1% BSA); 0.1% SDS; 10% dextran sulfate; and 100 g/ml boiled salmon sperm DNA. The hybridization buffer contained 10 6 dpm/ml 32 P-labeled probe, and hybridization was performed overnight at 50 C. The resulting membranes were washed twice in 2 ϫ NaCl/Cit (NaCl/Cit ϭ 150 mm NaCl and 15 mm sodium citrate, pH 7.4)-0.1% SDS at room temperature for 15 min each, then twice in NaCl/Cit-0.1% SDS at 50 C for 10 min and autoradiographed by exposure to Kodak XOmat-AR films (Eastman Kodak, Rochester, NY) for 4 -8 days at Ϫ70 C.
Statistical analysis
All values are the mean Ϯ sem. The significance of the differences between the mean values from each testis of the same fetus was evaluated by Student's paired t test. Other means were compared using one-way ANOVA (Fisher's test).
Results

IGF-I mRNA in fetal testis
Northern blot analysis of RNA from the testes of 20.5-day-old fetuses showed a major IGF-I transcript of 7-7.5 kb and two minor transcripts of 3.9 and 1.8 kb. The pattern of IGF-I transcripts was similar in fetuses and immature testis (Fig. 2) .
In vivo testicular content and in vitro secretion of IGF-I by fetal testis
Fetal day 16.5 testis contained 18.3 Ϯ 1.6 pg/testis IGF-I (n ϭ 6), and 20.5 fetal day testis contained 77.8 Ϯ 3 pg/testis (n ϭ 6) IGF-I. The testicular IGF-I/protein ratio did not vary significantly with age. Fetal testes in organ culture secreted immunoreactive IGF-I, which became detectable on the second day in culture (Fig. 3) . This production was age dependent and increased with time in culture. The IGF-I content of day 16.5 fetal testes after 5 days in culture was 18.7 Ϯ 2.5, and that of 20.5 day-old fetuses was 78.8 Ϯ 5 pg/testis (n ϭ 6). These values were similar to those measured at the beginning of the culture (Fig.  3) . Consequently, IGF-I seems to be synthesized by the fetal testis in organ culture.
The effects of LH, FSH, or (Bu) 2 cAMP on IGF-I secretion by testes explanted on day 20.5 of fetal life were investigated. Eight testes were pooled on the same Millipore filter and cultured for 5 days in control medium or in medium containing 100 ng/ml oLH, 200 mIU/ml hFSH, or 1 mm (Bu) 2 cAMP. None of these factors was able to modify IGF-I secretion (Fig. 4) .
Effect of IGF-I on testosterone production by fetal testes in culture
Testes removed from fetuses on fetal days 13.5, 16.5, 18.5, and 20.5 were cultured for 3 days in the absence (Fig. 5A) or presence (Fig. 5B ) of 100 ng/ml LH, with or without 50 ng/ml IGF-I. IGF-I did not alter the basal or LH-stimulated testosterone secretions regardless of the age of the testis.
Effect of IGF-I on testosterone production by dispersed fetal testicular cells in culture as a function of age and duration of culture
After a preculture on D0, cells from day 16.5 and 20.5 fetal testes were cultured in the presence or absence of IGF-I (50 ng/ml) or insulin (50 ng/ml) for 3 days (D1 to D3). LH (100 ng/ml) was added to all media to prevent a rapid decline in testosterone secretion from occurring in the absence of gonadotropin stimulation. In the absence of IGF-I and insulin, the amount of testosterone secreted by day 16.5 cells increased throughout the course of culture (Fig. 6 ). This increase was greater when insulin and/or IGF-I were added to the medium. The effect of IGF-I was significantly greater than that of insulin. There was no additive effect of insulin and IGF-I. The amount of testosterone secreted by fetal day 20.5 cells cultured with LH alone also increased during the first and second days in culture, but not thereafter. Adding IGF-I and/or insulin further increased testosterone production, but this effect was less pronounced than for day 16.5 cells. There was, again, no additive effect of insulin and IGF-I.
Effects of LH and IGF-I on proliferation and differentiation of cultured fetal Leydig cells
After a preculture on D0, cells from day 16.5 and 20.5 fetal testes were cultured for 3 days (D1 to D3) in the presence or absence of LH (100 ng/ml) with or without IGF-I (50 ng/ml). The total number of cells and the number of 3␤HSD-positive cells were counted at the end of D0 and D3 (Fig. 7, A and B) .
For cells taken from 16.5-day-old fetuses cultured without LH and IGF-I, the total number of cells present in the well increased in culture, whereas the number of 3␤HSD-positive cells slightly decreased. LH had no effect on the total number of cells, but increased the number of 3␤HSD-positive cells. IGF-I gave a 150% increase in the total number of cells and a 250% increase in the number of 3␤HSD-positive cells. LH did not modify the effect of IGF-I on testicular cells, but potentiated its effect on 3␤HSD-positive cells.
For day 20.5 cells cultured in the presence of LH, the total number of testicular cells did not significantly change during culture and was unaffected by the addition of IGF-I, The number of 3␤HSD-positive cells decreased during culture, and IGF-I prevented this decrease.
To evaluate the mitotic activity of the fetal Leydig cells, BrdU was added for 3 h at the end of D3 in culture of day 16.5 cells, and the percentage of 3␤HSD-positive cells in which BrdU was detected was determined (Fig. 7C) . In the absence of LH and IGF-I, this percentage was very low, but it was significantly increased in response to LH or IGF-I. Furthermore, the effects of LH and IGF-I were additive.
Effects of LH, IGF-I, and insulin on testosterone production by cultured fetal Leydig cells
To evaluate the steroidogenic activity of fetal Leydig cells, the amount of testosterone secreted into the medium on D3 was divided by the number of 3␤HSD-positive cells counted at the end of this day (Fig. 8) . In the absence of LH, day 16.5 fetal Leydig cells secreted minute amounts of testosterone. Both IGF-I and insulin caused an increase in testosterone secretion. For cells cultured in the presence of LH, large amounts of testosterone were produced per 3␤HSD-positive cells on D3 (Fig. 8) . IGF-I or insulin further increased this production for day 16.5 cells, but not for day 20.5 cells. For cultures in the presence of (Bu) 2 cAMP, the positive effect of IGF-I was less than that in the presence of LH. 
Discussion
We have measured the production of IGF-I and its control by gonadotropins in the rat testis during fetal development. Northern blot analysis revealed the expression of one major IGF-I transcript of 7-7.5 kb and two minor transcripts of 3.8 and 1.8 kb in day 20.5 fetal testis. This pattern of expression is similar to those previously reported in the testis of the immature rat (36, 37) .
IGF-I was detected in the fetal testis as early as fetal day 16.5. Until now, the youngest stage studied showing IGF-I protein in the testis was postnatal day 3 (9) . Testes from day 16.5 and 20.5 fetuses contained very little IGF-I before or after culture compared with the amounts secreted into the medium, indicating a high de novo synthesis in vitro. This production increased with age at explantation and with time in culture. This increasing production of IGF-I with time also occurred in cultures of Leydig and Sertoli cells from immature rats and piglets (12, 13) , but the reason for it is unknown.
Gonadotropins and (Bu) 2 cAMP did not alter the secretion of IGF-I by the fetal testis in vitro. This is in contrast to the situation in immature and adult testes. LH and FSH increase IGF-I mRNA in the testes of immature hypophysectomized rats (37) . IGF-I secretion by immature Leydig and Sertoli cells in culture is also stimulated by LH (Leydig) and FSH (Sertoli) in the rat (12) and the pig (13, 38) . In contrast, hCG decreases the amount of IGF-I mRNA in purified Leydig cells from adult rats (39) . These results, therefore, suggest that the regulation of IGF-I production by gonadotropins is age dependent and is not yet established at fetal stages.
The second part of our study examined the effect of IGF-I on fetal Leydig cell function using organotypic and dispersed fetal Leydig cell cultures. IGF-I did not alter testosterone secretion by organotypic cultures at any of the stages studied. On the contrary, IGF-I increased the number of Leydig cells in cultures of day 16.5 and 20.5 fetal cells and had a positive effect on steroidogenesis only by day 16.5 cells. There are at least three possible explanations for the difference between our two in vitro systems. First, the organ cultures were performed on Millipore filters, and IGF-I can be absorbed by the filter. However, this possibility must be discarded, because IGF-I had no effect on testosterone produced by testes cultured on stainless steel grids (data not shown). Second, in several studies, IGFBPs have been shown to inhibit the positive effects of IGF-I on Leydig cell functions (40, 41) . Thus, if the cultured testes contained a concentration of endogenously produced IGFBPs it could inhibit the effect of IGF-I. However, no IGFBP was detected in our culture medium by Western blotting (data not shown), suggesting that IGFBPs are not involved to any major degree. Third, the local IGF-I concentration in organ cultures could be very high, so that the biological effect is maximal; therefore, exogenous IGF-I may not stimulate testosterone secretion. This is supported by data from immature rats showing that IGF-I has no action in cocultures of Leydig and Sertoli cells pretreated with LH plus FSH (42) . However, addition of anti-IGF-I antiserum to this coculture decreased steroid output, suggesting a maximal para/autocrine effect of endogenous secreted IGF-I. In contrast, the concentration of secreted IGF-I is low in our dispersed fetal testicular cells cultures and is probably insufficient to cause a maximal biological effect. Indeed, partial removal of tubular cells during the preparation of dispersed cells may contribute to a lower IGF-I secretion because tubular cells are the main source of IGF-I in neonatal testis (9) . Other studies in our laboratory have shown the same difference in the effect of transforming growth factor-␤1 as a function of the culture system. This factor inhibits testosterone production by dispersed fetal Leydig cells in culture, but has no effect in organotypic culture (30) .
Using a dispersed fetal Leydig cell culture system validated previously (30, 43) , this study reports for the first time a positive effect of IGF-I on fetal Leydig cell proliferation, differentiation, and function. We also used this model to study the effect of LH during the onset of steroidogenesis (day 16.5), although in vivo fetal Leydig cell differentiation, proliferation, and function are LH independent until fetal day 19.5 (32, 44) . (46, 47) and immature pigs (19) , but not that of mature rat Leydig cells (16) . Recent studies of IGF-I gene knock-out mice have shown that in these animals the number of adult Leydig cells was markedly reduced (25) , confirming the effects of IGF-I on cell multiplication and maturation of precursors of adulttype Leydig cells. IGF-I may also act by decreasing apoptosis of Leydig cells. However, although it has been shown that IGF-I may protect cells from apoptosis in some cell types (48) no antiapoptotic effect on Leydig cells has been reported until now.
The steroidogenic functions of day 16.5 fetal Leydig cells in culture rapidly and strongly decreased in the absence of LH, revealing an intense dedifferentiation in vitro. IGF-I partially reduced this dedifferentiation. When cultures were performed in the presence of LH, high amounts of testosterone were produced per 3␤HSD-positive cells. IGF-I further increased this production. Thus, our results clearly demonstrated that IGF-I potentiates the steroidogenic effect of LH on fetal Leydig cells when both factors are added together. In the same way, it has been demonstrated that IGF-I alone has long term trophic effects on the differentiated functions of immmature and adult Leydig cells (reviews in Refs. 5, 6, 49, and 50) .
In the present study, the trophic effect of IGF-I on the steroidogenic activity was higher in the presence of LH than in the presence of (Bu) 2 cAMP, suggesting that IGF-I acts on both upstream and downstream steps of the cAMP pathway. IGF-I also acts at sites both proximal and distal to cAMP generation in adult type Leydig cells. It increases the number of LH/hCG receptors (16, 20) and the amounts of LH/hCG receptor mRNA (21) as well as the activities of several steroidogenic enzymes and their mRNA concentrations (6, 15, (21) (22) (23) .
Interestingly, the positive effects of IGF-I on the steroidogenic activity of fetal day 16.5 Leydig cells do not occur in fetal day 20.5 cells. Similarly, the ability of IGF-I to cause an increase in the number of 3␤HSD-positive cells in vitro was largely reduced from day 16.5 to day 20.5. These developmental changes correlate well with the in vivo development of fetal Leydig cell number and function. During fetal development, Leydig cell number and function are strongly increasing on fetal day 16.5, while the number of Leydig cells per testis stops increasing around day 20.5 (51) , and the testosterone production per Leydig cell becomes stable or even declines (31, 52) . Hence, IGF-I could be an important regulator of the development of steroidogenesis in the fetal testis.
There is considerable evidence that insulin plays a role in the regulation of testosterone production by adult-type Leydig cells, and there are insulin receptors on purified rat Leydig cells (16, 53) . Insulin also stimulates testosterone production by purified rat and pig Leydig cells (16, 19) . We find that insulin has a positive effect on the steroidogenic activity of fetal day 16.5 cells. As the insulin concentrations used were low, it is unlikely that it acted via the IGF-I receptor. This is the first evidence that insulin receptors are present on rat Leydig cells during fetal life. The positive effect of insulin on steroidogenesis by fetal day 16.5 Leydig cells was not found with fetal day 20.5 cells as it was for IGF-I. As the concentration of insulin in the fetal plasma on day 16.5 is undetectable, and it is very high on day 20.5 (54), the physiological role of insulin in the control of fetal testicular steroidogenesis remains to be established.
In conclusion, we have demonstrated that IGF-I is present in the fetal testis, has a mitogenic effect on Leydig cells from 16.5 day-old fetuses, and stimulates their differentiation from mesenchymal cells. These effects were weaker or absent in cells from fetal day 20.5 testes. These results can be linked to the development of Leydig cells in vivo and thus provide evidence that IGF-I has a paracrine/autocrine action on Leydig cell function and differentiation during early development. 
